Avantor Inc
(NYSE:AVTRpA.PFD)
$
90.81
0 (0%)
Market Cap: -
Enterprise Value: -
PE Ratio: 50.20
PB Ratio: 2.77
GF Score: 76/100 Avantor Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript
Nov 29, 2022 / 05:10PM GMT
Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics Team
Okay. Thanks, everyone, for joining us this afternoon. A pleasure to have with us Avantor. We have the CEO, Michael Stubblefield, with us this afternoon.
Questions & Answers
Vijay Muniyappa Kumar
Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics Team
Michael, when I look at life sciences 3Q, it's been a lot of moving parts there have been, whether it was some stocking dynamics in bioprocessing or macro, et cetera, and different companies have said different things, right? And I think for you guys specifically, you had a guidance change on the core. Maybe let's start with like a big picture question, right? I think if I just keep it very simple, other tools companies did not take their core down, Avantor took the core down. Is the share lost for Avantor? And how would you
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot